Actinium Pharmaceuticals Stock Price History
| ATNM Stock | USD 1.55 0.14 9.93% |
Below is the normalized historical share price chart for Actinium Pharmaceuticals extending back to June 02, 2011. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Actinium Pharmaceuticals stands at 1.55, as last reported on the 23rd of March, with the highest price reaching 1.57 and the lowest price hitting 1.38 during the day.
If you're considering investing in Actinium Stock, it is important to understand the factors that can impact its price. Actinium Pharmaceuticals appears to be very risky, given 3 months investment horizon. Actinium Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0944, which signifies that the company had a 0.0944 % return per unit of risk over the last 3 months. By analyzing Actinium Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.5% is justified by implied risk. Please makes use of Actinium Pharmaceuticals' Downside Deviation of 4.32, risk adjusted performance of 0.0879, and Mean Deviation of 4.11 to double-check if our risk estimates are consistent with your expectations.
At this time, Actinium Pharmaceuticals' Issuance Of Capital Stock is very stable compared to the past year. As of the 23rd of March 2025, Stock Based Compensation To Revenue is likely to grow to 44.82, while Common Stock is likely to drop about 23.9 K. . At this time, Actinium Pharmaceuticals' Price To Sales Ratio is very stable compared to the past year. As of the 23rd of March 2025, Price Book Value Ratio is likely to grow to 3.51, while Price Earnings To Growth Ratio is likely to drop (0.07). Actinium Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 27th of December 2012 | 200 Day MA 2.7894 | 50 Day MA 1.2078 | Beta 0.108 |
Actinium |
Sharpe Ratio = 0.0944
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ATNM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.29 actual daily | 47 53% of assets are more volatile |
Expected Return
| 0.5 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Actinium Pharmaceuticals is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Actinium Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 1.2655 | Enterprise Value Ebitda (3.62) | Price Sales 596.9586 | Shares Float 31 M | Wall Street Target Price 5 |
Actinium Pharmaceuticals Stock Price History Chart
There are several ways to analyze Actinium Stock price data. The simplest method is using a basic Actinium candlestick price chart, which shows Actinium Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 21, 2025 | 1.55 |
| Lowest Price | March 3, 2025 | 1.06 |
Actinium Pharmaceuticals March 23, 2025 Stock Price Synopsis
Various analyses of Actinium Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Actinium Stock. It can be used to describe the percentage change in the price of Actinium Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Actinium Stock.| Actinium Pharmaceuticals Price Action Indicator | 0.15 | |
| Actinium Pharmaceuticals Price Daily Balance Of Power | 0.74 | |
| Actinium Pharmaceuticals Price Rate Of Daily Change | 1.10 |
Actinium Pharmaceuticals March 23, 2025 Stock Price Analysis
Actinium Stock Price History Data
The price series of Actinium Pharmaceuticals for the period between Mon, Dec 23, 2024 and Sun, Mar 23, 2025 has a statistical range of 0.49 with a coefficient of variation of 7.87. The prices are distributed with arithmetic mean of 1.22. The median price for the last 90 days is 1.22. The company had 1:30 stock split on 11th of August 2020. Actinium Pharmaceuticals issued dividends on 2020-08-11.| Open | High | Low | Close | Volume | ||
03/23/2025 | 1.39 | 1.57 | 1.38 | 1.55 | ||
| 03/21/2025 | 1.39 | 1.57 | 1.38 | 1.55 | 616,041 | |
| 03/20/2025 | 1.29 | 1.49 | 1.27 | 1.41 | 1,711,517 | |
| 03/19/2025 | 1.23 | 1.23 | 1.16 | 1.21 | 209,023 | |
| 03/18/2025 | 1.28 | 1.30 | 1.18 | 1.19 | 228,799 | |
| 03/17/2025 | 1.26 | 1.30 | 1.23 | 1.30 | 187,594 | |
| 03/14/2025 | 1.24 | 1.26 | 1.21 | 1.23 | 124,850 | |
| 03/13/2025 | 1.17 | 1.22 | 1.16 | 1.20 | 244,012 | |
| 03/12/2025 | 1.17 | 1.17 | 1.12 | 1.15 | 115,976 | |
| 03/11/2025 | 1.11 | 1.15 | 1.09 | 1.15 | 128,420 | |
| 03/10/2025 | 1.10 | 1.13 | 1.09 | 1.12 | 119,030 | |
| 03/07/2025 | 1.13 | 1.14 | 1.10 | 1.14 | 59,766 | |
| 03/06/2025 | 1.14 | 1.15 | 1.12 | 1.14 | 95,222 | |
| 03/05/2025 | 1.10 | 1.16 | 1.08 | 1.15 | 201,820 | |
| 03/04/2025 | 1.06 | 1.12 | 1.03 | 1.10 | 210,779 | |
| 03/03/2025 | 1.17 | 1.17 | 1.06 | 1.06 | 214,333 | |
| 02/28/2025 | 1.11 | 1.16 | 1.09 | 1.15 | 113,980 | |
| 02/27/2025 | 1.10 | 1.15 | 1.10 | 1.10 | 144,572 | |
| 02/26/2025 | 1.14 | 1.16 | 1.11 | 1.11 | 171,417 | |
| 02/25/2025 | 1.16 | 1.20 | 1.12 | 1.15 | 140,123 | |
| 02/24/2025 | 1.17 | 1.18 | 1.12 | 1.17 | 122,751 | |
| 02/21/2025 | 1.24 | 1.26 | 1.17 | 1.17 | 124,122 | |
| 02/20/2025 | 1.16 | 1.23 | 1.15 | 1.23 | 130,783 | |
| 02/19/2025 | 1.24 | 1.28 | 1.17 | 1.17 | 172,196 | |
| 02/18/2025 | 1.17 | 1.28 | 1.17 | 1.26 | 318,230 | |
| 02/14/2025 | 1.12 | 1.16 | 1.12 | 1.15 | 94,159 | |
| 02/13/2025 | 1.11 | 1.13 | 1.07 | 1.10 | 174,853 | |
| 02/12/2025 | 1.10 | 1.12 | 1.07 | 1.09 | 129,207 | |
| 02/11/2025 | 1.13 | 1.15 | 1.10 | 1.11 | 190,110 | |
| 02/10/2025 | 1.16 | 1.16 | 1.12 | 1.13 | 161,983 | |
| 02/07/2025 | 1.15 | 1.18 | 1.11 | 1.12 | 219,713 | |
| 02/06/2025 | 1.23 | 1.23 | 1.15 | 1.15 | 125,701 | |
| 02/05/2025 | 1.20 | 1.23 | 1.17 | 1.23 | 142,186 | |
| 02/04/2025 | 1.19 | 1.23 | 1.17 | 1.17 | 143,621 | |
| 02/03/2025 | 1.15 | 1.18 | 1.10 | 1.18 | 257,559 | |
| 01/31/2025 | 1.23 | 1.24 | 1.16 | 1.16 | 266,198 | |
| 01/30/2025 | 1.24 | 1.26 | 1.18 | 1.22 | 145,825 | |
| 01/29/2025 | 1.30 | 1.30 | 1.23 | 1.23 | 133,854 | |
| 01/28/2025 | 1.28 | 1.31 | 1.26 | 1.29 | 163,202 | |
| 01/27/2025 | 1.30 | 1.33 | 1.27 | 1.29 | 123,160 | |
| 01/24/2025 | 1.34 | 1.35 | 1.28 | 1.29 | 135,740 | |
| 01/23/2025 | 1.32 | 1.34 | 1.30 | 1.34 | 70,113 | |
| 01/22/2025 | 1.32 | 1.35 | 1.30 | 1.32 | 125,421 | |
| 01/21/2025 | 1.39 | 1.43 | 1.30 | 1.30 | 270,149 | |
| 01/17/2025 | 1.22 | 1.40 | 1.22 | 1.40 | 457,771 | |
| 01/16/2025 | 1.22 | 1.23 | 1.18 | 1.22 | 140,301 | |
| 01/15/2025 | 1.23 | 1.27 | 1.20 | 1.22 | 122,779 | |
| 01/14/2025 | 1.27 | 1.27 | 1.17 | 1.22 | 234,671 | |
| 01/13/2025 | 1.30 | 1.30 | 1.24 | 1.26 | 118,500 | |
| 01/10/2025 | 1.29 | 1.31 | 1.25 | 1.28 | 216,857 | |
| 01/08/2025 | 1.39 | 1.42 | 1.31 | 1.31 | 166,153 | |
| 01/07/2025 | 1.43 | 1.47 | 1.36 | 1.39 | 207,325 | |
| 01/06/2025 | 1.45 | 1.48 | 1.39 | 1.43 | 283,783 | |
| 01/03/2025 | 1.27 | 1.45 | 1.27 | 1.44 | 388,265 | |
| 01/02/2025 | 1.27 | 1.34 | 1.25 | 1.26 | 468,686 | |
| 12/31/2024 | 1.19 | 1.28 | 1.17 | 1.26 | 580,470 | |
| 12/30/2024 | 1.20 | 1.22 | 1.16 | 1.17 | 418,720 | |
| 12/27/2024 | 1.28 | 1.29 | 1.18 | 1.20 | 477,781 | |
| 12/26/2024 | 1.20 | 1.29 | 1.17 | 1.29 | 296,428 | |
| 12/24/2024 | 1.24 | 1.24 | 1.15 | 1.22 | 141,941 | |
| 12/23/2024 | 1.28 | 1.29 | 1.19 | 1.24 | 301,837 |
About Actinium Pharmaceuticals Stock history
Actinium Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Actinium is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Actinium Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Actinium Pharmaceuticals stock prices may prove useful in developing a viable investing in Actinium Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 30.6 M | 32.1 M | |
| Net Loss | -29.7 M | -31.2 M |
Actinium Pharmaceuticals Quarterly Net Working Capital |
|
Actinium Pharmaceuticals Stock Technical Analysis
Actinium Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Money Managers Now
Money ManagersScreen money managers from public funds and ETFs managed around the world |
| All Next | Launch Module |
Actinium Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Actinium Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Actinium Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Actinium to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0879 | |||
| Jensen Alpha | 0.5839 | |||
| Total Risk Alpha | 0.9056 | |||
| Sortino Ratio | 0.1281 | |||
| Treynor Ratio | 0.3335 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Actinium Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Actinium Stock, please use our How to Invest in Actinium Pharmaceuticals guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Actinium Pharmaceuticals. If investors know Actinium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Actinium Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Actinium Pharmaceuticals is measured differently than its book value, which is the value of Actinium that is recorded on the company's balance sheet. Investors also form their own opinion of Actinium Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Actinium Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Actinium Pharmaceuticals' market value can be influenced by many factors that don't directly affect Actinium Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Actinium Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Actinium Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Actinium Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.